Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 7—July 2005

Dispatch

New Lymphogranuloma Venereum Chlamydia trachomatis Variant, Amsterdam

Joke Spaargaren*Comments to Author , Han S.A. Fennema*, Servaas A. Morré†, Henry J.C. de Vries‡, and Roel A. Coutinho§
Author affiliations: *Municipal Health Service, Amsterdam, the Netherlands; †VU University Medical Center, Amsterdam, the Netherlands; ‡Academic Medical Center, Amsterdam, the Netherlands; §National Institute of Public Health and Environment, Bilthoven, the Netherlands

Main Article

Table

Characteristics of men who have sex with men in retrospective study at sexually transmitted disease outpatient clinic in Amsterdam, the Netherlands*

Clinical data MMA+
MMA–
(2002 and 2003)
(2003)
C. trachomatis
C. trachomatis
L2b Non-LGV Total L2b Non-LGV Total
No. patients 32 12† 44 13 17‡ 30
Anal discharge 11 3 14 4 2 6
Genital ulcers 3 (L2b) 1 (Treponema pallidum) 4 0 1 (HSV-2) 1
Lymphadenopathy 4 0 4 2 2 4
Mean no. infections with sexually transmitted diseases 8.3 5.8 7.8 7 4.6 5.8
Known HIV+ 24 6 30 7 7 14
>10 leukocytes by Gram stain 26 3 39 3 6 9
C. trachomatis lgG ≥200 22 2 24 8 6 14
C. trachomatis lgG <200 10 18 11 15

*MMA, mucous membrane abnormalities; C. trachomatis, Chlamydia trachomatis; LGV, lymphogranuloma venereum; Ig, immunoglobulin.
†2 serum samples were not available for testing.
‡1 serum sample was not available for testing.
§Serogroup B, n = 5; intermediate serogroup, n = 5; serogroup C, n = 2.
¶Serogroup B, n = 10; intermediate serogroup, n = 1; serogroup C, n = 6.

Main Article

TOP